While obesity has been shown to impact prognosis negatively for both pre- and postmenopausal patients, the most prominent effects are seen in estrogen receptor alpha (ERα) positive postmenopausal patients, a finding confirmed by a recent retrospective analysis of the German BRENDA-cohort [9]. This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.